title: Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis.
abstract: OBJECTIVE
  Although autoimmune pancreatitis (AIP) has been recently recognized as a new disease entity of chronic pancreatitis, the clinical diagnosis of the disease remains disputed. Autoantibodies against carbonic anhydrase II and lactoferrin are detected in most patients with AIP, but not in about 10%. We undertook this study to determine whether additional autoantibodies are present in the serum level of AIP patients.
  
  
  METHODS
  We recruited 26 patients with AIP for the study. For comparison, we also recruited 53 patients with various pancreatic diseases and 12 healthy subjects. We immunoscreened human pancreatic cDNA library using patients' sera. Positive clones were analyzed by DNA sequencing and were constructed into a pGEX-4T-1 expression vector. The recombinant proteins were used as antigens in enzyme-linked immunosorbent assay to screen the subjects' sera for autoantibodies.
  
  
  RESULTS
  We cloned a cDNA encoding the pancreatic secretory trypsin inhibitor (PSTI). Among 26 patients with AIP, autoantibodies against PSTI were significantly positive in 11 (42.3%) by western blotting and in 8 (30.8%) by enzyme-linked immunosorbent assay, respectively. However, none of control subjects was positive for anti-PSTI antibodies.
  
  
  CONCLUSIONS
  These findings suggest that PSTI may be related to the pathogenesis of AIP, and autoantibodies against PSTI can be a useful diagnostic marker for the disease.
authors.affiliation: Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan. masanori@kuhp.kyoto-u.ac.jp
authors.forename: Masanori
authors.initials: M
authors.lastname: Asada
authors.forename: Akiyoshi
authors.initials: A
authors.lastname: Nishio
authors.forename: Kazushige
authors.initials: K
authors.lastname: Uchida
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kido
authors.forename: Satoru
authors.initials: S
authors.lastname: Ueno
authors.forename: Norimitsu
authors.initials: N
authors.lastname: Uza
authors.forename: Keiichi
authors.initials: K
authors.lastname: Kiriya
authors.forename: Satoko
authors.initials: S
authors.lastname: Inoue
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kitamura
authors.forename: Shinya
authors.initials: S
authors.lastname: Ohashi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Tamaki
authors.forename: Toshiro
authors.initials: T
authors.lastname: Fukui
authors.forename: Minoru
authors.initials: M
authors.lastname: Matsuura
authors.forename: Kimio
authors.initials: K
authors.lastname: Kawasaki
authors.forename: Toshiki
authors.initials: T
authors.lastname: Nishi
authors.forename: Norihiko
authors.initials: N
authors.lastname: Watanabe
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nakase
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Chiba
authors.forename: Kazuichi
authors.initials: K
authors.lastname: Okazaki
mesh_terms: D000368:Aged; D001323:Autoantibodies / Q000097:blood*; D001327:Autoimmune Diseases / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D024402:Carbonic Anhydrase II / Q000276:immunology; D003001:Cloning, Molecular; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005982:Glutathione Transferase; D006801:Humans; D007781:Lactoferrin / Q000276:immunology; D008297:Male; D008875:Middle Aged; D050500:Pancreatitis, Chronic / Q000097:blood*; D011993:Recombinant Fusion Proteins; D014359:Trypsin Inhibitor, Kazal Pancreatic / Q000235:genetics / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; D011993:Recombinant Fusion Proteins; D014359:Trypsin Inhibitor, Kazal Pancreatic; D005982:Glutathione Transferase; D007781:Lactoferrin; D024402:Carbonic Anhydrase II